| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1091255997 |
| P356 | DOI | 10.1038/S41598-017-09650-Y |
| P932 | PMC publication ID | 5567132 |
| P698 | PubMed publication ID | 28827719 |
| P2093 | author name string | Yang Zhou | |
| Jia-Ming Liu | |||
| Zhi-Li Liu | |||
| Ai-Fen Peng | |||
| Qing-Fu Yu | |||
| Wei-Lai Tong | |||
| P2860 | cites work | Cancer statistics, 2015 | Q27860576 |
| Lung cancer in elderly patients | Q28067234 | ||
| Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients | Q33904020 | ||
| Risk factors for bone metastasis in patients with primary lung cancer: study protocol for a systematic review | Q33996458 | ||
| Prediction of lymph node metastasis in patients with apparent early endometrial cancer | Q36107586 | ||
| Natural History of Non-Small-Cell Lung Cancer with Bone Metastases. | Q36393088 | ||
| Predictors of survival in patients with bone metastasis of lung cancer | Q36826129 | ||
| The Evolving Role of Histology in the Management of Advanced Non–Small-Cell Lung Cancer | Q37809678 | ||
| Incidence and predictors of Bone Metastases (BM) and Skeletal-Related Events (SREs) in Small Cell Lung Cancer (SCLC): A Swiss patient cohort | Q38791807 | ||
| Perioperative changes in serum CA125 levels: a prognostic factor for disease-specific survival in patients with ovarian cancer. | Q39256449 | ||
| Prognosis and predictors of site of first metastasis after definitive radiation therapy for non-small cell lung cancer | Q40812688 | ||
| Pleural cancer antigen-125 levels in benign and malignant pleural effusions | Q43590269 | ||
| Usefulness of bone markers for detection of bone metastases in lung cancer patients | Q44075427 | ||
| Evaluation of preoperative criteria used to predict lymph node metastasis in endometrial cancer. | Q51799352 | ||
| Distribution of distant metastases from newly diagnosed non-small cell lung cancer. | Q52302957 | ||
| Predictors of bone metastasis in pre-treatment staging of asymptomatic treatment-naïve patients with prostate cancer. | Q53117817 | ||
| Testing of a Novel Cancer Metastatic Multiplex Panel for the Detection of Bone-metastatic Disease - a Pilot Study. | Q53124210 | ||
| Prognostic Factors and Skeletal-Related Events in Patients with Small Cell Lung Cancer with Bone Metastases at the Time of Diagnosis. | Q53203847 | ||
| Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer. | Q53579751 | ||
| Combination of hemoglobin, alkaline phosphatase, and age predicts optimal docetaxel regimen for patients with castration-resistant prostate cancer. | Q54542174 | ||
| High levels of tumor markers in pleural fluid correlate with poor survival in patients with adenocarcinomatous or squamous malignant effusions | Q57531305 | ||
| Diagnostic utility of CYFRA 21-1, carcinoembryonic antigen, CA 125, neuron specific enolase, and squamous cell antigen level determinations in the serum and pleural fluid of patients with pleural effusions | Q59274557 | ||
| Potential of an age-stratified CA125 cut-off value to improve the prognostic classification of patients with endometrial cancer | Q61705507 | ||
| Routine bone scans in patients with prostate cancer related to serum prostate-specific antigen and alkaline phosphatase | Q74318421 | ||
| The relationship between lung cancer histology and the clinicopathological characteristics of bone metastases | Q89345473 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 8970 | |
| P577 | publication date | 2017-08-21 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | The risk factors of bone metastases in patients with lung cancer | |
| P478 | volume | 7 |
| Q90746043 | CA-125, CA-153, and CYFRA21-1 as clinical indicators in male lung cancer with ocular metastasis |
| Q90169517 | Circulating liver enzymes and risks of chronic diseases and mortality in the prospective EPIC-Heidelberg case-cohort study |
| Q92893677 | Diagnostic value of CA-153 and CYFRA 21-1 in predicting intraocular metastasis in patients with metastatic lung cancer |
| Q60949963 | Loss of Myeloid-Specific TGF-β Signaling Decreases CTHRC1 to Downregulate bFGF and the Development of H1993-Induced Osteolytic Bone Lesions |
| Q91839762 | Lung Cancer Cells Derived Circulating miR-21 Promotes Differentiation of Monocytes into Osteoclasts |
| Q64085635 | Nomogram based on homogeneous and heterogeneous associated factors for predicting bone metastases in patients with different histological types of lung cancer |
| Q90636815 | Ocular Metastasis in Elderly Lung Cancer Patients: Potential Risk Factors of CA-125, CA-153 and TPSA |
| Q57470947 | PET/CT features discriminate risk of metastasis among single-bone FDG lesions detected in newly diagnosed non-small-cell lung cancer patients |
| Q99403325 | Serum alkaline phosphatase is a prognostic marker in bone metastatic disease of the extremity |
| Q89848704 | The Value of Alkaline Phosphatase-to-Albumin Ratio in Detecting Synchronous Metastases and Predicting Postoperative Relapses among Patients with Well-Differentiated Pancreatic Neuroendocrine Neoplasms |
Search more.